Introduction {#sec0005}
============

*Cryptococcus* belongs to the fungal phylum of Blastomycota. It is an encapsulated yeast, found in soil. Systemic infections usually result from inhalation of spores or desiccated yeasts leading to primary pulmonary infection \[[@bib0005]\]. The pathogen shows tropism to the central nervous system. It rarely causes IE with most reported cases involving a cardiac prosthetic valve after surgery. This case presents a rare scenario of native valve infection in an immunocompetent host.

Case presentation {#sec0010}
=================

A 26 year old homeless smoker male with no other significant personal history was initially admitted after cardiac arrest related to drug overdose with development of acute renal failure following the event. Patient was started on dialysis but while the workup was pending, he left the hospital against medical advice. Patient was readmitted at another outlying facility within a week, with acute shortness of breath and left against medical advice again after improvement of symptoms following few sessions of hemodialysis. No significant family history was reported. Social history was significant for intravenous heroin, cocaine and methamphetamine use. He decided to seek care within a week and was admitted at our facility for further evaluation and management. Patient denied any recent camping or exposure to pigeon droppings through occupational or recreational exposure.

Physical examination was significant for tachycardia (heart rate 123 beats per minute) and tachypnea (respiratory rate of 25 breaths per minute). He had jugular venous distension, bilateral lower extremity and scrotal edema. Needle track marks were noted over the upper extremities. Chest radiograph showed cardiomegaly with pulmonary edema.

Complete blood count on admission showed white blood cell count of 13,000/uL, hemoglobin of 10.4 g/dL, and platelet count of 100,000/uL. A basic metabolic profile on admission was significant for potassium of 5.5 mmol/L and serum creatinine of 7.08 mg/dL. Nephrology was consulted and patient underwent emergent dialysis. Electrocardiogram showed sinus tachycardia with frequent ventricular complexes, no atrioventricular nodal block was noted. A transthoracic echocardiogram (TTE) was obtained due to clinical findings suggestive of heart failure. It showed a large mobile vegetation on the atrial surface of the tricuspid valve with severe tricuspid regurgitation. ([Fig. 1](#fig0005){ref-type="fig"}) Severe global hypokinesis with systolic ejection fraction of 25% was also noted. An echogenic non-mobile structure was noted on the posterior mitral leaflet with moderate mitral regurgitation ([Fig. 1](#fig0005){ref-type="fig"}). Transesophageal echocardiography (TEE) confirmed a 2.2 × 1 centimeter (cm) mobile vegetation on anterior leaflet of tricuspid valve and 1.5 × 0.8 cm mobile density on the posterior tricuspid valve. A 0.5 × 0.6 cm sessile echodensity was noted attached to posterior mitral valve that appeared calcified and consistent with old vegetation on the TEE. ([Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}). Records of care at outlying hospitals were finally obtained a few days after hospitalization at our facility. Blood cultures from other hospital showed 2 out of 2 sets of blood cultures positive for *Cryptococcus neoformans* from the initial facility, followed by 1 out of 2 sets positive for the same organisms 5 days later from patient's second admission. Repeat fungal blood cultures at our facility remained negative. Laboratory testing was done to rule out HIV and other underlying immunodeficiency with test results shown below in [Table 1](#tbl0005){ref-type="table"}.Fig. 1Transthoracic echocardiogram (TTE) showing tricuspid and mitral vegetations noted on apical fourchamber view. (RA-Right atrium, LA- Left Atrium, RV- Right ventricle, LV- Left ventricle, upward arrow showing mitral vegetation, downward arrow showing tricuspid vegetation).Fig. 1Fig. 2Transesophageal echocardiogram (TEE) showing large tricuspid vegetation on Midesophageal four-chamber view. (Downward arrow showing tricuspid vegetation).Fig. 2Fig. 3Transesophageal echocardiogram (TEE) showing mitral vegetation on Midesophageal mitral commissural view. (Downward arrow showing mitral vegetation).Fig. 3Table 1Laboratory test results to rule out underlying immunodeficiency and other pertinent test results.Table 1HIV 1,2 screen HIV-1 RNA PCRNegative Non detectableC-Reactive Protein3.32 mg/dLAbsolute CD4 count1328/cubic milliliterSerum Cryptococcal AntigenNegativeBrucella SerologyIgG, IgM negativeQ fever SerologynegativeC3 complement level114 mg/dlC4 complement level25.4 mg/dlHepatitis C antibody Hepatitis C RNA PCRPositive Non detectableImmunoglobulin G1589 mg/dLImmunoglobulin A295 mg/dLImmunoglobulin M137 mg/dL

Computed tomographic images of the lungs and abdomen showed patchy confluent opacities of bilateral lungs suggestive of septic emboli. A 2.2 cm hypo dense sub-capsular lesion was seen in spleen which possibly presented a septic emboli as well. Lumbar puncture was performed to rule out central nervous system cryptococcal disease with findings as shown in [Table 2](#tbl0010){ref-type="table"}.Table 2Lumbar Puncture result.Table 2ComponentvalueReferenceunitsCSF Total Nucleated cells100--5/mm3CSF Neutrophils1%%CSF Lymphocytes98%%CSF Cryptococcal PCRNegativeNegative--CSF Cryptococcal AntigenNegativeNegativeCSF glucose5240--70mg/dlCSF Protein20.512--60mg/dlCSF Gram stainNegativeCSF CultureNegative

Records confirmed that patient was treated with liposomal Amphotericin-B for three days at outlying hospital before he had left against medical advice. On admission at our facility, while waiting to obtain records from other hospital, patient was started empirically on vancomycin 1000 mg and gentamicin 80 mg intermittent intravenous (IV) therapy with dialysis for suspected bacterial endocarditis. Liposomal Amphotericin-B 6milligram/kg and Fluconazole 400 mg IV once daily was started once fungal cultures with growth of *Cryptococcus* were obtained. Cardiothoracic surgery was consulted who recommended against emergent surgery due to patient's social situation and high operative risk.

Due to high risk for being lost to follow up, patient completed 6 weeks of liposomal Amphotericin-B treatment while inpatient. Prior incomplete treatment with Amphotericin-B at outlying hospital was likely the cause of negative serum Cryptococcal Antigen testing at our facility and made the diagnosis very challenging. After completing intravenous Fluconazole therapy while inpatient, he was discharged home on oral Fluconazole 400 mg every 48 h after hemodialysis for 6 months. Flucytosine therapy was recommended but patient refused to take the medication due to concerns about side effects. On subsequent follow-up, patient was noted to be compliant with treatment and did not need any surgical intervention. Patient was seen at the infectious disease follow up clinic 3 months after discharge with weekly follow up of C-Reactive protein that trended down within normal range. Repeat fungal and bacterial blood cultures done one month after discharge showed no growth. Repeat transthoracic echocardiogram in one month showed anterior tricuspid valve vegetation 1.2 × 2.4 cm in size and septal vegetation was 0.9cmx1.9 cm in size. The mitral valve vegetation size on repeat echocardiogram was 1cmx0.5 cm. Another transesophageal echocardiogram done approximately nine months after initial presentation showed ejection fraction of 60%.Small dense lesion on posterior mitral leaflet and a 1.3 × 0.3 cm lesion on anterior leaflet of tricuspid valve was seen with significant calcification, likely representing healed vegetation.

Discussion {#sec0015}
==========

*Cryptococcus* endocarditis is a rare disease with very few cases reported in immunocompetent hosts. In 2009, Park et al. reported over 600,000 annual deaths from Cryptococcal infection in sub-saharan Africa alone \[[@bib0010]\]. *Cryptococcus neoformans* primarily lives in the yeast form and most people are exposed to it at young age in epidemic areas. Most cases are minimally symptomatic and the infection is rapidly cleared by immune system, though, in immunosuppressed patients, it has emerged as an important opportunistic infection \[[@bib0015]\]. The virulence of the organism is speculated to be due to a polysaccharide capsule that protects the pathogen in environment and within the host by several mechanisms such as downregulating inflammatory cytokines, inhibiting antigen presenting capacity of monocytes, regulating phagocytosis by macrophages and also providing antioxidant property to protect the pathogen from reactive oxygen generated by the host \[[@bib0020], [@bib0025], [@bib0030], [@bib0035]\].

The spectrum of disease due to the pathogen ranges from self-limiting skin infection to more devastating systemic infections in immunocompromised hosts. It most commonly causes central nervous system (CNS) infection such as meningoencephalitis. Disease in individuals with no apparent immunodeficiency is not very common \[[@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060]\]. Lui et al. performed a retrospective case series of *Cryptococcus* infections, reporting 20 out of 46(43.5%) cases were immunocompetent \[[@bib0065]\]. Other extra-pulmonary and extra-CNS cryptococcal infections reported include prosthetic joint infection, small bowel infection, bullous cellulitis, sarcoid like reaction, septic arthritis and palatal mass \[[@bib0070], [@bib0075], [@bib0080], [@bib0085], [@bib0090], [@bib0095], [@bib0100]\].

Cardiac involvement due to *Cryptococcus* infection can present with pericarditis, myocarditis and endocarditis, especially in immunocompromised host and in the presence of prosthetic valves \[[@bib0105], [@bib0110]\]. Fungal endocarditis accounts for approximately 6% of cases of infective endocarditis \[[@bib0115]\]. *Cryptococcus* is a rare fungal pathogen to cause endocarditis, with Candida, Aspergillus and Histoplasma species being more commonly implicated in causing fungal IE. The risk factors for fungal endocarditis are the same factors as those identified for bacterial endocarditis, such as, intravenous drug use, prosthetic heart valves, structural heart disease and HIV. Our patient did have the risk factor of intravenous drug use, and a possible cause of cryptococcal bloodstream infection was needle contamination.

Cryptococcal endocarditis is extremely rare and has been reported in post-operative prosthetic valve infections \[[@bib0120], [@bib0125], [@bib0130], [@bib0135], [@bib0140], [@bib0145]\]. Lombardo et al. reported the first case of *Cryptococcus* endocarditis in 1957 \[[@bib0125]\]. Clinical presentation of fungal endocarditis is usually the same as bacterial endocarditis but a high index of suspicion is needed to send the fungal blood cultures, otherwise the diagnosis can be delayed. Cultures in special media such as Sabouraud dextrose agar, brain-heart infusion agar, or canavanine-glycine-bromothymol blue are needed for isolation of fungi \[[@bib0150]\]. A single center study of fungal endocarditis reported much higher mortality with fungal pathogens as compared to bacterial counterpart \[[@bib0155]\].

[Table 3](#tbl0015){ref-type="table"} shows a brief review of reported cases since the first reported case in 1957. Three of the five cases had infection of prosthetic heart valves, with one case of rheumatic heart disease complicated with superimposed infection. There has been one reported case of native valve infection where the patient had known history of diabetes leading to immunosuppression and increased risk of infection \[[@bib0130]\]. Our case is the first reported case of *Cryptococcus neoformans* endocarditis of native valve with no known history of underlying immunosuppressed state.Table 3Brief review of reported cases.Table 3YearAuthorsProsthetic ValveNative ValveImmunospressionTreatmentValves involvedRef in Text1957Lombardo et alNoRheumatic Heart Diseasenoactidione,sulfadiazineMitral and Aortic\[[@bib0130]\]1967Colmers et alNoYesYesAmphoteticin BMitral, History of Mitral stenosis\[[@bib0125]\]1983Boden et alyesnoYesAmphotericin B and SurgeryAortic\[[@bib0120]\]1997Bannerjee et alyesNoNoAmphotericin BMitral\[[@bib0115]\]2011Alhaji et alyesNoNoAmphotericin BAortic\[[@bib0135]\]

Most case reports have emphasized the use of Amphotericin-B in the treatment of Cryptococcal endocarditis, with or without surgical intervention. Due to paucity of reported cases, no randomized trials(RCT) have been done to give clinicians a guideline based on RCTs to follow or to compare Amphotericin-B therapy with surgical management. Alhaji et al. in 2011 reported a case of prosthetic valve endocarditis successfully treated with Amphotericin-B \[[@bib0140]\]. Colmers et al. in 1967 reported success with medical therapy as well \[[@bib0130]\]. Our patient was considered a high risk for surgery, therefore medical management as chosen. The patient was successfully treated with IV liposomal Amphotericin-B followed by a prolonged course of oral fluconazole without the need for any surgical intervention.
